Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Profound Medical Corp T.PRN

Alternate Symbol(s):  PROF

Healthcare Medical Devices
Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure... see more

Recent & Breaking News (TSX:PRN)

Profound Medical Corp. and Philips Sell TULSA-PRO™ System to UCL and UCLH

GlobeNewswire June 20, 2016

Profound Medical Corp. to hold Annual General Meeting of the Shareholders

GlobeNewswire June 7, 2016

FDA Grants Profound Medical Corp. IDE Approval for TULSA-PRO™

GlobeNewswire May 19, 2016

Investor Calendar Invites You to the Profound Medical Corp. First Quarter 2016 Earnings Conference Call Live on Monday, May 9, 2016

Accesswire May 6, 2016

Profound Medical Corp. To Present at Upcoming Conference

GlobeNewswire April 29, 2016

Profound Medical Corp. to Release First Quarter 2016 Financial Results on May 6, 2016

GlobeNewswire April 29, 2016

Profound Medical Corp. Announces World's First Sale of TULSA-PRO for Prostate Ablation

GlobeNewswire April 28, 2016

Profound Medical Corp., receives CE Mark Approval for TULSA-PRO(TM)

GlobeNewswire April 11, 2016

Profound Medical Corp. Announces Full Year 2015 Financial Results

GlobeNewswire March 2, 2016

Investor Calendar Invites You to the Profound Medical Corp. Full Year 2015 Earnings Conference Call Live on Thursday, March 3, 2016

Accesswire March 2, 2016

Profound Medical Corp. and Siemens Enter Into Strategic Agreement to Further the Development of Prostate Cancer Care

GlobeNewswire February 29, 2016

Profound Medical Corp. to Release Full Year 2015 Financial Results on March 3, 2016

GlobeNewswire February 25, 2016

Profound Medical Corp. Announces Publication in European Urology

GlobeNewswire January 8, 2016

Profound Medical Named 2016 Life Science Company of the Year

GlobeNewswire November 27, 2015

Profound Medical Corp. Announces Departure of CFO

GlobeNewswire November 17, 2015

Profound Medical Corp. Announces Third Quarter 2015 Financial Results

GlobeNewswire November 4, 2015

Hartmut Warnken Joins Profound Medical as Vice President, International Sales

GlobeNewswire November 2, 2015

Profound Medical Corp. to Release Third Quarter 2015 Financial Results on November 4, 2015

GlobeNewswire October 28, 2015

Profound Medical to Present at Upcoming Investor Conferences

GlobeNewswire October 21, 2015

Profound Medical Presents Successful 12-Month Phase I Outcomes at the European Symposium on Focused Ultrasound Therapy

GlobeNewswire October 15, 2015